Review: Catechol O-methyl transferase inhibitors plus L-dopa and some surgical interventions improve Parkinson disease symptoms: COMMENTARY

Jog, Mandar
March 2004
ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, p42
Academic Journal
The article comments on a study conducted to study the efficacy of different medical interventions to improve the symptoms in patients with early or advanced Parkinson disease (PD). The study reviewed current PD treatment, including pharmacologic, physiotherapeutic, surgical, and psychiatric interventions. Several studies in the use of DAs for the treatment of PD have been published. The review methodology is well explained, and the inclusion of studies seems reasonable. Unfortunately, studies on DAs plus L-dopa within the past 3 years were not included in this meta-analysis.


Related Articles

  • Review: Catechol O-methyl transferase inhibitors plus L-dopa and some surgical interventions improve Parkinson disease symptoms.  // ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, p42 

    The article examines if pharmacologic, surgical, psychiatric, or ancillary interventions can improve symptoms in patients with early or advanced Parkinson disease (PD). Studies were selected if they were randomized controlled trials (RCTs) of pharmacologic, psychiatric, surgical, or ancillary...

  • Early Versus Delayed Initiation of Pharmacotherapy in Parkinson's Disease. Löhle, Matthias; Ramberg, Carl-Johan; Reichmann, Heinz; Schapira, Anthony // Drugs;Apr2014, Vol. 74 Issue 6, p645 

    Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease and pathologically is characterised by a progressive loss of dopaminergic cells of the nigrostriatal pathway. Clinically, PD is mainly defined by the presence of the motor symptoms of...

  • Rotigotine Transdermal Patch in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Zhou, Chang-Qing; Li, Shan-Shan; Chen, Zhong-Mei; Li, Feng-Qun; Lei, Peng; Peng, Guo-Guang // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Background and Methods: The efficacy and safety of rotigotine transdermal patch in Parkinson’s disease (PD) were studied in some clinical trials. We performed a systematic review and meta-analysis of randomized controlled trials to evaluate the efficacy, tolerability, and safety of...

  • Gene-based Therapies in Parkinson's Disease. Allen, Patricia; Feigin, Andrew // Neurotherapeutics;Jan2014, Vol. 11 Issue 1, p60 

    Parkinson's disease (PD) is a progressive neurological disorder characterized primarily by the degeneration of nigrostriatal dopaminergic neurons and diminution of the neurotransmitter dopamine. Though dopamine replacement therapies such as levodopa can improve the symptoms of PD, the benefits...

  • Rotigotine: in Parkinson's disease. Reynolds, Neil A.; Wellington, Keri; Easthope, Stephanie E. // CNS Drugs;2005, Vol. 19 Issue 11, p973 

    Rotigotine is a nonergolinic dopamine D3/D2/D1 receptor agonist delivered via a transdermal system and has been evaluated for the treatment of idiopathic Parkinson's disease. Patients with early Parkinson's disease receiving rotigotine monotherapy experienced significantly greater improvements...

  • Health Care IT: Process, People, Patients and Interdisciplinary Considerations. Payton, Fay Cobb; Par�, Guy; LeRouge, Cynthia; Reddy, Madhu // Journal of the Association for Information Systems;Feb2011, Vol. 12 Issue 2, pi 

    The article discusses several important benefits of health care information technology (IT) in the U.S. These benefits include improved access to patient care, enhanced ability to conduct clinical trials of new diagnostic methods and treatments, and streamlined monitoring of public health...

  • Reengineering the Process. Giannasi, Nick // Applied Clinical Trials;May2012 Supplement, p8 

    The article discusses the advancement in the field of clinical trial. It notes the use of remote device to continuously monitor clinical trial participants. It indicates that continuous monitoring facilitates subject recruitment, improves participant retention, and eliminates inefficient...

  • Untitled.  // Electronics Weekly;1/27/2010, Issue 2413, p24 

    The article informs that Toumaz Technology has started clinical trials to verify that the physiological data acquired by the digital plaster system within a clinical setting in a hospital is equivalent to that acquired using current monitoring systems. It is evident that digital plaster is based...

  • Multimodal neuromonitoring. Macas, Andrius; Bilskienė, Diana; Gembickij, Aleksandr; Žarskus, Ainius; Rimaitis, Marius; Vilkė, Alina; Šuškevičienė, Ilona; Rugytė, Danguolė; Tamašauskas, Arimantas // Acta Medica Lituanica;2012, Vol. 19 Issue 3, p180 

    The goal of the intensive care management of a neurosurgical patient is to preserve adequate cerebral perfusion, oxygenation and metabolism in order to prevent secondary neurological injury. In preventing secondary neurological insults interventions must be started early. For many years...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics